Skip to main content
European Journal of Radiology Open logoLink to European Journal of Radiology Open
. 2015 May 16;2:71–80. doi: 10.1016/j.ejro.2015.05.001

Diffusion weighted imaging and diffusion tensor imaging in the evaluation of transplanted kidneys

Stefano Palmucci a,, Giuseppina Cappello a, Giancarlo Attinà a, Pietro Valerio Foti a, Rita Olivia Anna Siverino a, Federica Roccasalva a, Marina Piccoli a, Nunziata Sinagra b, Pietro Milone a, Massimiliano Veroux b, Giovanni Carlo Ettorre a
PMCID: PMC4750625  PMID: 26937439

Abstract

Objective

The aim of this study is to investigate the relation between renal indexes and functional MRI in a population of kidney transplant recipients who underwent MR with diffusion-weighted imaging (DWI) and diffusion tensor imaging (DTI) of the transplanted graft.

Method

Study population included 40 patients with single kidney transplant. The patients were divided into 3 groups, on the basis of creatinine clearance (CrCl) values calculated using Cockcroft-Gault formula: group A, including patients with normal renal function (CrCl ≥ 60 mL/min); group B, which refers to patients with moderate renal impairment (CrCl > 30 but <60 mL/min); and, finally, group C, which means severe renal deterioration (CrCl ≤ 30 mL/min). All patients were investigated with a 1.5 Tesla MRI scanner, acquiring DWI and DTI sequences. A Mann–Whitney U test was adopted to compare apparent diffusion coefficients (ADCs) and fractional anisotropy (FA) measurements between groups. Receiver operating characteristic (ROC) curves were created for prediction of normal renal function (group A) and renal failure (group C). Pearson correlation was performed between renal clearance and functional imaging parameter (ADC and FA), obtained for cortical and medullar regions.

Results

Mann–Whitney U test revealed a highly significant difference (p < 0.01) between patients with low CrCl (group C) and normal CrCl (group A) considering both medullar ADC and FA and cortical ADC. Regarding contiguous groups, the difference between group B and C was highly significant (p < 0.01) for medullar ADC and significant (p < 0.05) for cortical ADC and medullar FA. No difference between these groups was found considering cortical FA. Analyzing groups A and B, we found a significant difference (p < 0.05) for medullar both ADC and FA, while no difference was found for cortical ADC and FA.

Strongest Pearson correlation was found between CrCl and medullar ADC (r = 0.65). For predicting normal renal function or severe renal impairment, highest values of AUC were observed using medullar ADC cut-off values (respectively 0.885 and 0.871); medullar FA showed also high accuracy (respectively 0.831 and 0.853).

Conclusions

DWI and DTI are promising tools for non-invasive monitoring of renal function; medullar ADC proved to be the best parameter for renal function assessment.

Abbreviations: DWI, diffusion weighted imaging; ADC, apparent diffusion coefficient; DTI, diffusion tensor imaging; FA, fractional anisotropy; CrCl, creatinine clearance; ROI, region of interest; ROC, receiver operating characteristic curve; AUC, area under the curve

Keywords: Magnetic resonance imaging, Diffusion weighted MRI, Diffusion tensor imaging, Kidney transplantation

1. Introduction

Renal graft function is monitored using clinical parameters – such as serum creatinine, creatinine clearance – and imaging modalities, mainly represented by ultrasound, ecocolor-doppler and scintigraphy; however, the assessment of renal disease requires parenchymal biopsy to make a correct diagnosis, grading also the level of damage. Renal biopsy is an invasive procedure, not free from complications (hemorrhage, infection, etc.). In a recent study by Franke et al., a not-irrelevant number of complications (perirenal/retroperitoneal bleeding, hematuria, arterio-venous fistula) have been found; indeed, the complication rate was 4.1% [1].

The possibility of investigating renal function is one of the most recent goals of functional MRI; namely, this potentiality has been gradually increased in importance due to the fact that gadolinium enhanced MRI has a non-negligible degree of nephrotoxicity [2], [3].

In the past decade, several articles have pointed out the role of functional MRI in the evaluation of kidney diseases [4]. DWI has been used to characterize focal renal lesions [5], and to investigate renal function, either in normal kidneys [6] or renal graft also [7].

All renal functions, such as glomerular filtration, tubular reabsorption and secretion, are based on water transportation [8]. Thus, quantification of Brownian motions measured by DWI may provide a functional assessment of renal parenchyma. Diffusion and perfusion effects are expressed by a numerical value, named ADC, which decreases with restriction of diffusion of water molecules. ADC is defined as “an average index of how freely water can move within a voxel (i.e. averaged across all tissue structures and compartments within the voxel) and hence the term apparent” [9].

However, molecular motility may not be the same in all directions, leading to a certain anisotropy. It can be due for example to an obstacle limiting molecular movements or to the anatomic orientation of the structures of the tissue. DTI is able to evaluate diffusion anisotropy measuring diffusion of water molecules for each single direction of the gradient pulses. DTI allows us to obtain in vivo information about oriented tissues, such as brain white matter, muscles and myocardium [10]. Its role has been emphasized in brain study, particularly in patients with brain tumors to evaluate displacement or interruption of white matter pathways, and in demyelinating disease to detect subtle changes in myelin fibers integrity [11]. As in brain white matter, also in renal medulla there is an intrinsic orientation of the structures because it is assembled in tubuli and ducti with parallel coarse. Thus, several studies have pointed out that normal renal architecture suggest a different evaluation of diffusion direction using DTI, that could be able to evaluate the degree of medullary anisotropy [12].

The purpose of our study was to evaluate the usefulness of DWI and DTI in assessing allograft dysfunction correlating ADC and FA values with laboratory data; diagnostic accuracy of ADC and FA is calculated, in order to investigate which is the most useful parameter for the evaluation of renal function.

2. Material and methods

2.1. Study population

Patients were enrolled between September 2014 and January 2015. This study was approved by our internal ethics committee and a written informed consent was obtained from all patients before MRI.

Study population included forty patients with single kidney transplant (24 males, 16 females) with a mean age of 50.6 years (range, 17–78). 32 of them received transplant from deceased donor, 8 from living donor. A serum creatinine value was collected no more than 36 h before or after MRI examination.

Patients received a standard immunosuppressive protocol with a calcineurin inhibitor (tacrolimus in 27 and cyclosporine in 13), mycophenolatemofetil and steroids. None of the patients experienced an episode of acute rejection during the study period. MRI examinations were performed at a mean post-transplant time of 3.8 years (range, 8 days-22.8 years). No patients were excluded from this study.

Kidney transplantations, clinical management and follow-up were performed by the same surgical team. All transplanted kidneys were placed in the right iliac fossa with vascular anastomoses to the common or external iliac vessels. The patients were divided into 3 groups, on the basis of CrCl values calculated using Cockcroft-Gault formula:

  • -

    group A, patients with CrCl ≥ 60 mL/min;

  • -

    group B, patients with CrCl > 30 but <60 mL/min;

  • -

    group C, patients with CrCl ≤ 30 mL/min.

2.2. MRI protocol

All examinations were performed using a 1.5 Tesla scanner (SignaHDxt, General Electric). Images were acquired with an 8-channels array coil (8 channel body coil), using the lower configuration; sequences were not respiratory-triggered, so that no “respiratory” belt was used.

Unenhanced T1 and T2-weighted sequences were performed before DTI in order to obtain a morphological evaluation of transplanted kidneys. Axial sequences were positioned perpendicularly to the major axis of the kidney (Fig. 1). No intravenous hypotonic agent was administrated. Protocol examination included:

  • -

    Axial T2-weighted Fast Recovery Fast Spin Echo sequence, obtained with a TR = 3200 ms, TE = 110 ms, thickness = 5 mm, gap interval = 0.5 mm, Number of Excitations = 4, matrix = 320 × 224, Field of View = 36–40;

  • -

    Coronal T2-weighted Fast Recovery Fast Spin Echo sequence, obtained with a TR = 3100 ms, TE = 103 ms, thickness = 3 mm, gap interval = 0.3 mm, Number of Excitations = 4, matrix = 320 × 224;

  • -

    Diffusion-weighted sequences, obtained by Single Shot Echo Planar Imaging technique, using a b value of 500. Namely, acquisition parameters were the following: TR = 3000 ms; TE = 40–79 ms; Number of Excitations = 2; acceleration factor = 2; EPI factor = 80; thickness = 5 mm; spacing = 1 mm; Field of View = 34–42; matrix = 128 × 128, acquisition time = 1 min 42 s.

  • -

    DTI was acquired using a “free-breathing” Single Shot Echo Planar Imaging technique, with diffusion gradient active for 6 directions. Acquisition parameters were: TR = 7500 ms; TE = 86 ms; Number of Excitations = 4; acceleration factor = 2; EPI factor = 80; thickness = 6 mm; spacing = 1 mm; Field of View = 34–42 cm; matrix = 128 × 128, acquisition time = 3 min 38 s.

Fig. 1.

Fig. 1

Axial b = 0 (a), ADC map (b) and FA map (c) images of a 52-year old woman with good renal function (CrCl = 104 mL/min). FA map shows good visual differentiation between cortical and medullar parenchyma.

2.3. Image analysis

Morphological evaluation of the transplanted kidney was performed using axial and coronal T2-weighted sequences. We investigated both vascular and non vascular complications that may affect transplanted kidneys, such as focal or diffuse parenchymal signal alterations, perirenal fluid collections, lymphoceles, arterial, venous and collecting system abnormalities. These conditions, which can occur both in the early postoperative period and in the long-term, must be recognized because they influence the transplanted patients’ outcome. ADC and FA were calculated by placing a circular ROI both in the cortical and in the medulla for each transplanted kidney in three different levels: upper, middle and lower third. For positioning of cortical and medullar ROIs, anatomical T2-weighted acquisitions and b = 0 images were used.

The ROIs were always placed avoiding all possible inclusions of vessels and focal lesions. A mean score was obtained for both cortical and medullar ADC values and for both cortical and medullar FA values. Post-processing was performed using the General Electric Functool software package (GE Healthcare®).

2.4. Statistical analysis

Statistical analysis was performed using Win-Stat Software and a MedCalc program (MedCalc version 11.4.4.0, MedCalc Software bvba, Mariakerke, Belgium).

Cortical and medullar ADC and FA mean values were compared among the three different groups using the Mann–Whitney U test; p < 0.05 was considered statistically significant. Both cortical and medullar ADC and FA were correlated to Cr Clusing Pearson linear regression.

Lastly, optimal ADC and FA threshold values for group membership were determined by ROC analysis, calculating corresponding sensitivities, specificities and diagnostic accuracies.

3. Results

3.1. Qualitative analysis

Morphologic imaging showed absence of renal disease in 23 patients. No vascular complications – such as renal artery stenosis or partial vein thrombosis – were found. MRI demonstrated 5 fluid collections and 6 lymphoceles located in renal graft area, behind the iliac vessels or near the inguinal region. A renal mass was found in 1 patient. In 2 patients renal pelvis dilatation was demonstrated. 3 cases of pyelonephritis were also found.

3.2. Quantitative analysis

The patients’ distribution into 3 groups, on the basis of CrCl, was as follow (Table 1): 10 patients in group A (4 males and 6 females, with a mean age of 51.2 years); 12 patients in group B (8 males and 4 females, with a mean age of 48.7 years); 18 patients in group C (12 males and 6 females, with a mean age of 51.6 years).

Table 1.

Study population: CrCl, cortical ADC, medullar ADC, Cortical FA and medullar FA mean values of each patient.

Group A Group B Group C
CrCl ≥60 mL/min
CrCl >30 < 60 mL/min
CrCl ≤30 mL/min
PT ClCr ADC cort ADC med FA cort FA med PT ClCr ADC cort ADC med FA cort FA med PT ClCr ADC cort ADC med FA cort FA med
2 67 2.31 2.36 0.265 0.233 3 45 1.75 2.17 0.278 0.230 1 17 2.63 2.30 0.213 0.149
4 94 2.57 2.41 0.288 0.347 6 55 2.36 2.09 0.203 0.154 5 21 2.19 2.40 0.264 0.139
7 71 2.39 2.54 0.315 0.231 10 42 2.14 2.36 0.179 0.202 9 4 2.23 1.82 0.203 0.156
8 104 2.56 2.18 0.187 0.311 11 36 2.63 1.93 0.232 0.263 12 15 1.62 1.75 0.245 0.172
13 72 2.19 2.48 0.217 0.340 17 34 2.13 1.90 0.229 0.204 14 7 1.97 1.83 0.319 0.177
15 116 2.90 2.55 0.193 0.267 20 50 2.10 2.16 0.074 0.261 16 28 1.62 1.79 0.280 0.100
19 92 2.48 2.55 0.204 0.262 22 32 1.99 2.03 0.171 0.142 18 30 2.16 2.36 0.224 0.284
27 99 2.26 2.40 0.267 0.197 25 44 2.04 2.61 0.289 0.190 21 26 1.83 1.95 0.176 0.225
31 74 2.20 2.46 0.183 0.474 29 34 2.13 2.30 0.223 0.222 23 18 1.88 2.08 0.238 0.213
34 93 1.89 1.96 0.188 0.213 33 51 2.54 2.39 0.318 0.260 24 10 2.14 1.66 0.201 0.103
36 57 2.36 2.23 0.246 0.328 26 20 1.86 1.92 0.152 0.156
39 52 1.88 2.04 0.151 0.225 28 9 1.96 1.91 0.166 0.118
30 15 1.87 1.79 0.120 0.111
32 11 1.91 1.71 0.193 0.103
35 30 1.80 1.98 0.294 0.191
37 24 1.75 1.94 0.178 0.197
38 29 1.70 1.84 0.202 0.275
40 19 1.50 1.64 0.305 0.190

Abbreviations: PT = patient; CrCl = creatinine clearance; ADC cort = mean cortical ADC; ADC med = mean medullar ADC; FA cort = mean cortical FA; FA med = mean medullar FA.

Comparing mean values of cortical ADC (Fig. 2), we did not observe a significant difference (p = 0.06) between groups A and B, whereas we found a highly significant difference (p < 0.01) in the comparison between groups A and C, and a statistically significant difference between groups B and C (p = 0.02).

Fig. 2.

Fig. 2

Box-and-whisker plot for cortical ADC values (a–c): considering cortical ADC measurement, we found a significant statistical difference only comparing groups B and C (b) and groups A and C (c). No difference was observed for cortical ADC measurements between group A and B (a).

Comparing mean values of medullar ADC (Fig. 3) we observed a significant difference (p = 0.02) between groups A and B; a highly significant difference (p < 0.01) was reported between groups A and C, and between groups B and C.

Fig. 3.

Fig. 3

Box-and-whisker plot for medullar ADC measurements (a–c): comparing mean values between groups A and B (a) we observed a significant difference (p = 0.02). Comparing groups B and C (b), the difference was highly significant, with a p < 0.01. Highly significant difference (p < 0.01) was reported in the comparison between groups A and C (c).

Comparing mean values of cortical FA (Fig. 4) we did not observe a significant difference comparing groups A and B (p = 0.74), groups A and C (p = 0.63), and groups B and C (p = 0.98).

Fig. 4.

Fig. 4

Box-and-whisker plot for cortical FA values (a–c): no difference was observed comparing mean values between groups A and B (a), between groups B and C (b) and between groups A and C (c).

Comparing mean values of medullar FA (Fig. 5) between groups A and B, we observed a significant difference (p = 0.03). In the comparison between groups A and C, we observed a highly significant difference (p < 0.01). For medullar FA, the difference reported between groups B and C, was also significant (p = 0.02).

Fig. 5.

Fig. 5

Box-and-whisker plot for medullar FA measurements (a–c): comparing mean values between groups A and B (a), we observed a significant difference (p = 0.03). In comparing groups B and C (b), the difference was also significant (p = 0.02). In the comparison between groups A and C (c), we observed a highly significant difference (p < 0.01).

Pearson correlation test showed a strong positive correlation between CrCl and medullar FA (Fig. 6a), with a coefficient of 0.62 while cortical FA showed no correlation with r value < 0.1. For ADC values a positive correlation was found between medullar ADC and CrCl, with r coefficient of 0.66 (Fig. 6b). A moderate positive correlation was reported between cortical ADC and CrCl, with r coefficient of 0.57.

Fig. 6.

Fig. 6

Scatter diagrams of Pearson correlation between medullar FA and ClCr (a), and medullar ADC and CrCl (b), both showing a strong correlation (respectively r = 0.62 and r = 0.66).

ROC analysis for prediction of normal clearance values or advanced renal impairment using ADC and FA mean values, are shown in Fig. 7, Fig. 8 respectively.

Fig. 7.

Fig. 7

ROC curves in prediction of group A: the ROC curve (a) shows an AUC of 0.871, with a sensitivity of 77.8% and specificity of 86.4% in the prediction of low creatinine clearance values (group C) using a threshold medullar ADC value ≤1.98 × 10−3 mm2/s. AUC of 0.814 (b), with a sensitivity of 72.2% and specificity of 86.4% was found using a threshold cortical ADC value ≤1.97 × 10−3 mm2/s. The ROC curve (c) shows an AUC of 0.831, with a sensitivity of 77.8% and specificity of 81.8% using a threshold medullar FA value ≤0.197 × 10−3 mm2/s. Finally (d) an AUC value of 0.527, with a sensitivity of 27.8% and specificity of 86.4%, was reported using a threshold cortical FA value ≤0.178 × 10−3 mm2/s.

Fig. 8.

Fig. 8

ROC curves in prediction of group C: the ROC curve (a) shows an AUC of 0.885, with a sensitivity of 80% and specificity of 83.3% in the prediction of normal creatinine clearance values (group A) using a threshold medullar ADC value >2.3 × 10−3 mm2/s. AUC of 0.832 (b), with a sensitivity of 90% and specificity of 76.7% was found using a threshold cortical ADC value >2.16 × 10−3 mm2/s. The ROC curve (c) shows an AUC of 0.853, with a sensitivity of 80% and specificity of 80% using a threshold medullar FA value >0.23 × 10−3 mm2/s. Finally (d), an AUC value of 0.550, with a sensitivity of 100% and specificity of 30%, was reported using a threshold cortical FA value >0.179 × 10−3 mm2/s.

In the prediction of renal low clearance values (patients of group C), using a threshold cortical ADC value ≤1.97 × 10−3 mm2/s, the ROC curve showed an AUC of 0.814, a 95% Confidence Interval (CI) for the area = 0.660–0.919, with sensitivity of 72.2% and specificity of 86.4%; for prediction of normal renal function (group A), using a threshold cortical ADC value >2.16 × 10−3 mm2/s, the ROC curve showed an AUC of 0.832, 95% CI = 0.680–0.931, with sensitivity of 90% and specificity of 76.7%.

In the prediction of renal low clearance values (group C), using a threshold medullar ADC value ≤1.98 × 10−3 mm2/s, 95% CI = 0.727–0.956, the ROC curve showed an AUC of 0.871, with sensitivity of 77.8% and specificity of 86.4%. For the prediction of renal normal clearance values (patients of group A) using a threshold medullar ADC value >2.3 × 10−3 mm2/s, 95% CI = 0.744–0.964, the ROC curve showed an AUC of 0.885, with sensitivity of 80% and specificity of 83.3%.

In the prediction of renal low clearance values (patients of group C) using a threshold cortical FA value ≤0.178 × 10−3 mm2/s, 95% CI = 0.363–0.686, the ROC curve showed an AUC of 0.527, with sensitivity of 27.8% and specificity of 86.4%. For prediction of renal normal clearance values (patients of group A) using a threshold cortical FA value >0.179 × 10−3 mm2/s, 95% CI = 0.385–0.707, the ROC curve showed an AUC of 0.550, with sensitivity of 100% and specificity of 30%.

In the prediction of renal low clearance values (patients of group C) using a threshold medullar FA value ≤0.197 × 10−3 mm2/s, 95% CI = 0.679–0.930, the ROC curve showed an AUC of 0.831, with sensitivity of 77.8% and specificity of 81.8%. For prediction of renal normal clearance values (group A), using a threshold medullar FA value >0.23 × 10−3 mm2/s, the ROC curve showed an AUC of 0.853, 95% CI = 0.706–0.945, with sensitivity of 80% and specificity of 80%.

4. Discussion

Several authors have investigated the role of DTI for evaluation of normal and injured kidneys. Gurses et al. and Wang et al. showed the feasibility of renal diffusion tensor imaging and repeatability of FA measurements [13], [14]. Other authors tried to correlate DTI parameters measurements to renal function in patients with chronic kidney diseases [15], [16], [17]. In particular, all these authors agree that decrease of FA values of renal parenchyma reflects severity of renal damage. Liu et al. found a positive correlation between FA and eGFR (estimated glomerular filtration rate): r = 0.689 for cortex and r = 0.696 for medulla [15]. Wang et al. demonstrated that cortical and medullar ADC and FA values were significantly lower in patients with chronic kidney disease than those of healthy volunteers: these values showed negative correlation with serum creatinine and blood urea nitrogen [16]. Gaudiano et al. investigated the role of FA values in a wide spectrum of chronic kidney diseases, showing that only medullary FA could be a marker of renal structural integrity alterations [17].

In addition, Lu et al. studied early changes of DT parameters in diabetic nephropathy finding lower mean medullary FA and ADC values among diabetics with relatively intact renal function (eGFR ≥ 60 ml/min/1.73 m2) compared to healthy controls. These findings suggest that medullary both FA and ADC may identify early changes in diabetics [18].

Diffusion MRI has been used also to evaluate renal allograft function [19], [20], [21]. Palmucci et al. evaluated the role of ADC measurements in transplanted kidney finding an ADC threshold ≥2.08 × 10−3 mm2/s to predict a normal clearance, although a certain overlap between groups [19].

Hueper et al. studied DTI as non-invasive tool for detection of allograft dysfunctions finding a significant reduction of medullar FA in transplanted kidneys compared to healthy volunteers. They also found a strong correlation between mean FA in the medulla and eGFR (r = 0.72) [20].

In a recent work by Lanzman et al. [21], the relationship between FA, ADC and renal function was analyzed. They divided patients into two groups according to eGFR: group A (eGFR > 30 mL/min/1.73 m2) and group B (eGFR ≤ 30 mL/min/1.73 m2). Cortex and medulla ADC values showed higher values in patients of group A, compared with patients with impaired function [21]. Mean FA values for cortex and medulla were significantly higher in group A (0.39 ± 0.06 and 0.17 ± 0.4), in comparison with group B (0.27 ± 0.05 and 0.14 ± 0.03) [21]. There was significant correlation between eGFR and medullary FA, with a r value of 0.65 (p < 0.01) [21].

Several theories have been proposed to explain water diffusion reduction in renal diseases.

In cases of renal dysfunction, filtration rate is low and water transport processes decrease [22]. All pathogenetic features of graft rejection, such as inflammation, edema, necrosis and fibrosis [23], decrease renal water content, perfusion and interstitial spaces reducing molecular extracellular free diffusion and resulting in a decrease of ADC [7].

Namely, in interstitial fibrosis, collagen deposition narrows spaces between tubuli, and water diffusion becomes reduced. Recent experience by Togao et al. has already confirmed this fact: these researchers stopped ureteral excretion in rats to evaluate ADC behavior in renal fibrosis. They found an ADC decrease related to an increased number of cells, including fibroblasts, concluding that “ADC has the potential to serve as a sensitive noninvasive biomarker of renal fibrosis” [24]. Also Zhao et al., in a recent study, correlated pathological fibrosis score with ADC decrease in patients with chronic renal diseases, finding a good correlation [25].

In our study, the Mann–Whitney U test revealed a highly significant difference (p < 0.01) between patients with low CrCl (group C) and normal CrCl (group A) considering both medullar ADC and FA and cortical ADC. Regarding contiguous groups, difference between patients with intermediate creatinine clearance (group B) and patients of group C was highly significant (p < 0.01) for medullar ADC and significant (p < 0.05) for cortical ADC and medullar FA. No difference between these groups was found considering cortical FA. Analyzing groups A and B, we found a significant difference (p < 0.05) for medullar both ADC and FA, while no difference was found for cortical ADC and FA.

We found a good correlation between creatinine clearance and medullar ADC (r = 0.65), and between creatinine clearance and medullar FA (r = 0.62). A moderate correlation was observed between creatinine clearance and cortical ADC (r = 0.56), while cortical FA did show no correlation. In contrast with previous study of Lanzman et al. [21], cortical FA values were not significantly different in our Mann–Whitney analysis; a certain degree of overlap was observed, with medians of 0.211 in group A, 0.226 in group B and 0.208 in group C. Probably, different repartition of patients could explain this degree of overlap; however, it has to be noted that cortical FA did not show correlation also in the previously mentioned study by Lanzman [21].

In both prediction of group C and group A, medullar ADC revealed the best accuracy, showing an AUC of 0.871, with sensitivity of 77.8% and specificity of 86.4%, but also medullar FA showed a high accuracy.

Limitations of this study were the small number of patients enrolled, as well as the absence of histopathologic correlation. In addition, a higher magnetic field strength would have provided a better signal-to-noise ratio, higher values of FA and better images quality [26], [27], [28].

A certain degree of overlap for ADC and FA values among the three different classes studied represents a limit.

Another limitation is that we used only six encoding directions: as demonstrated in a study by Chuck et al., a higher number of encoding directions results in better image quality and improved cortico-medullary discrimination, although it does not influence FA values. Although the longer acquisition time, “the increase in image quality allows for a more precise data evaluation when placing ROIs for FA measurements” [29].

5. Conclusion

These results emphasized the role of DWI in evaluation of transplanted kidney: medullar ADC resulted the best parameter for renal assessment, distinguishing between patients with good, moderate or impaired renal function. A medullar ADC value of 2.3 may be used as a threshold for predicting a normal clearance level. In our study, also medullar FA values good correlated with renal functionality, although in a slightly lower degree. However, a certain degree of overlap between ADC and FA values, among the three different classes, seems to limit use of functional MR in daily clinical practice.

References

  • 1.Franke M., Kramarczyk A., Taylan C., Maintz D., Hoppe B., Koerber F. Ecoguidata biopsia renale percutanea in 295 bambini e adolescenti: il ruolo della ecografia e analisi delle complicanze. PLOS ONE. 2014;9(dicembre (12)):e114737. doi: 10.1371/journal.pone.0114737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Perez-Rodriguez J., Lai S., Ehst B.D., Fine D.M., Bluemke D.A. Nephrogenic systemic fibrosis: incidence, associations and effect of risk factor assessment – report of 33 cases. Radiology. 2009;250(February (2)):371–377. doi: 10.1148/radiol.2502080498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Canga A., Kislikova M., Martìnez-Galvez M., Arias M., Fraga-Rivas P., Poyatos C. Renal function, nephrogenic systemic fibrosis and other adverse reactions associated with gadolinium-based contrast media. Nefrologia. 2014;34(4):428–438. doi: 10.3265/Nefrologia.pre2014.Apr.12375. [DOI] [PubMed] [Google Scholar]
  • 4.Gilet A.G., Kang S.K., Kim D., Chandarana H. Advanced renal mass imaging: diffusion and perfusion MRI. Curr Urol Rep. 2012;13:93–98. doi: 10.1007/s11934-011-0227-8. [DOI] [PubMed] [Google Scholar]
  • 5.Paudyal B., Paudyal P., Tsushima Y., Oriuchi N., Amanuma M., Miiyazaki M. The role of the ADC value in the characterisation of renal carcinoma by diffusion-weighted MRI. Br J Radiol. 2010;83(April (988)):336–343. doi: 10.1259/bjr/74949757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Faletti R., Cassinis M.C., Fonio P., Grasso A., Battisti G., Bergamasco L. Diffusion-weighted imaging and apparent diffusion coefficient values versus contrast-enhanced MR imaging in the identification and characterisation of acute pyelonephritis. Eur Radiol. 2013;23(12):3501–3508. doi: 10.1007/s00330-013-2951-6. [DOI] [PubMed] [Google Scholar]
  • 7.Palmucci S., Mauro L.A., Veroux P., Failla G., Milone P., Ettorre G.C. Magnetic resonance with diffusion-weighted imaging in the evaluation of transplanted kidneys: preliminary findings. Transplant Proc. 2011;43(May (4)):960–966. doi: 10.1016/j.transproceed.2011.01.157. [DOI] [PubMed] [Google Scholar]
  • 8.Abou-El-Ghar M.E., El-Diasty T.A., El-Assmy A.M., Refaie H.F., Refaie A.F., Ghoneim M.A. Role of diffusion-weighted MRI in diagnosis of acute renal allograft dysfunction: a prospective preliminary study. Br J Radiol. 2012;85(June (1014)):e206–e211. doi: 10.1259/bjr/53260155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Van A.T., Granziera C., Bammer R. An introduction to model-independent diffusion magnetic resonance imaging. Top Magn Reson Imaging. 2010;21(December (6)):339–354. doi: 10.1097/RMR.0b013e31823e6303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Le Bihan D., Mangin J.F., Poupon C., Clark C.A., Pappata S., Molko N. Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging. 2001;13(April (4)):534–546. doi: 10.1002/jmri.1076. [DOI] [PubMed] [Google Scholar]
  • 11.Pagani E., Bammer R., Horsfield M.A., Rovaris M., Gass A., Ciccarelli O. Diffusion MR imaging in multiple sclerosis: technical aspects and challenges. AJNR Am J Neuroradiol. 2007;28(March (3)):411–420. [PMC free article] [PubMed] [Google Scholar]
  • 12.Fukuda Y., Ohashi I., Hanafusa K., Nakagawa T., Ohtani S., Annaka Y. Anisotropic diffusion in kidney: Apparent Diffusion Coefficient measurements for clinical use. J Magn Reson Imaging. 2000;11:156–160. doi: 10.1002/(sici)1522-2586(200002)11:2<156::aid-jmri12>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  • 13.Gürses B., Kiliçkesmez O., Tasdelen N., Firat Z., Gürmen N. Diffusion tensor imaging of the kidney at 3 Tesla MRI: normative values and repeatability of measurements in healthy volunteers. Diagn Interv Radiol. 2011;17(December (4)):317–322. doi: 10.4261/1305-3825.DIR.3892-10.1. [DOI] [PubMed] [Google Scholar]
  • 14.Wang W.J., Pui M.H., Guo Y., Hu X.S., Wang H.J., Yang D. MR diffusion tensor imaging of normal kidneys. J Magn Reson Imaging. 2014;40(November (5)):1099–1102. doi: 10.1002/jmri.24450. [DOI] [PubMed] [Google Scholar]
  • 15.Liu Z., Xu Y., Zhang J., Zhen J., Wang R., Cai S. Chronic kidney disease: pathological and functional assessment with diffusion tensor imaging at 3T MR. Eur Radiol. 2015;25(March (3)):652–660. doi: 10.1007/s00330-014-3461-x. [DOI] [PubMed] [Google Scholar]
  • 16.Wang W.J., Pui M.H., Guo Y., Wang L.Q., Wang H.J., Liu M. 3T magnetic resonance diffusion tensor imaging in chronic kidney disease. Abdom Imaging. 2014;39(August (4)):770–775. doi: 10.1007/s00261-014-0116-y. [DOI] [PubMed] [Google Scholar]
  • 17.Gaudiano C., Clementi V., Busato F., Corcioni B., Orrei M.G., Ferramosca E. Diffusion tensor imaging and tractography of the kidneys: assessment of chronic parenchymal diseases. Eur Radiol. 2013;23(June (6)):1678–1685. doi: 10.1007/s00330-012-2749-y. [DOI] [PubMed] [Google Scholar]
  • 18.Lu L., Sedor J.R., Gulani V., Schelling J.R., O’Brien A., Flask C.A. Use of diffusion tensor MRI to identify early changes in diabetic nephropathy. Am J Nephrol. 2011;34(5):476–482. doi: 10.1159/000333044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Palmucci S., Mauro L.A., Failla G., Foti P.V., Milone P., Sinagra N. Magnetic resonance with diffusion-weighted imaging in the evaluation of transplanted kidneys: updating results in 35 patients. Transplant Proc. 2012;44(September (7)):1884–1888. doi: 10.1016/j.transproceed.2012.06.045. [DOI] [PubMed] [Google Scholar]
  • 20.Hueper K., Gutberlet M., Rodt T., Gwinner W., Lehner F., Wacker F. Diffusion tensor imaging and tractography for assessment of renal allograft dysfunction-initial results. Eur Radiol. 2011;21(November (11)):2427–2433. doi: 10.1007/s00330-011-2189-0. [DOI] [PubMed] [Google Scholar]
  • 21.Lanzman R.S., Ljimani A., Pentang G., Zgoura P., Zenginli H., Kröpil P. Kidney transplant: functional assessment with diffusion-tensor MR imaging at 3T. Radiology. 2013;266(January (1)):218–225. doi: 10.1148/radiol.12112522. [DOI] [PubMed] [Google Scholar]
  • 22.Ries M., Jones R.A., Basseau F., Moonen C.T., Grenier N. Diffusion tensor MRI of the human kidney. J Magn Reson Imaging. 2001;14(July (1)):42–49. doi: 10.1002/jmri.1149. [DOI] [PubMed] [Google Scholar]
  • 23.Park W.D., Griffin M.D., Cornell L.D., Cosio F.G., Stegall M.D. Fibrosis with inflammation at one year later predicts transplant functional decline. J Am Soc Nephrol. 2010;21(November (11)):1987–1997. doi: 10.1681/ASN.2010010049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Togao O., Doi S., Kuro-o M., Masaki T., Yorioka N., Takahashi M. Assessment of renal fibrosis with diffusion-weighted MR imaging: study with murine model of unilateral ureteral obstruction. Radiology. 2010;255(June (3)):772–780. doi: 10.1148/radiol.10091735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Zhao J., Wang Z.J., Liu M., Zhu J., Zhang X., Zhang T. Assessment of renal fibrosis in chronic kidney disease using diffusion-weighted MRI. Clin Radiol. 2014;69(November (11)):1117–1122. doi: 10.1016/j.crad.2014.06.011. [DOI] [PubMed] [Google Scholar]
  • 26.Seo Y., Wang Z.J., Morriss M.C., Rollins N.K., Minimum SNR and acquisition for bias-free estimation of fractional anisotropy in diffusion tensor imaging – a comparison of two analytical techniques and field strengths. Magn Reson Imaging. 2012;30(October (8)):1123–1133. doi: 10.1016/j.mri.2012.04.015. [DOI] [PubMed] [Google Scholar]
  • 27.Lee S.K. Diffusion tensor and perfusion imaging of brain tumors in high-field MR imaging. Neuroimaging Clin N Am. 2012;22(May (2)):123–134. doi: 10.1016/j.nic.2012.02.001. ix. [DOI] [PubMed] [Google Scholar]
  • 28.Chung A.W., Thomas D.L., Ordidge R.J., Clark C.A. Diffusion tensor parameters and principal eigenvector coherence: relation to b-value intervals and field strength. Magn Reson Imaging. 2013;31(June (5)):742–747. doi: 10.1016/j.mri.2012.11.014. [DOI] [PubMed] [Google Scholar]
  • 29.Chuck N.C., Steidle G., Blume I., Fischer M.A., Nanz D., Boss A. Diffusion tensor imaging of the kidneys: influence of b-value and number of encoding directions on image quality and diffusion tensor parameters. J Clin Imaging Sci. 2013;3(November):53. doi: 10.4103/2156-7514.122323. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from European Journal of Radiology Open are provided here courtesy of Elsevier

RESOURCES